63.4 2.1% 99.0 3.2% 35.6 56.2% Net Profit Attributable to Equity Holders of the Company 115.2 3.9% -187.3 -6.0% -302.4 -262.6% Revenue Analysis The total revenue in Q1/2018 was equivalent to 3,112.8
debentures or use a working capital to repay as scheduled. In addition, the resolution of the Annual General Meeting of Shareholders for the year 2022 held on June 24, 2022 had approved the issuance and
Company’s operation. The Company also has the debentures totaling 3,800 million baht that will mature within 12 months, which the Company can issue new debentures or use a working capital to repay as
., Ltd. registered in Thailand with initial registered capital of THB 700 million, in which the company holds 100% share, to conduct businesses regarding bio-based products business operation, and to
financing cost stood at 2.80% Net debt to equity ratio stood at 0.16x Capital Structure As of June 30, 2018, CPN reported total interest-bearing debt of THB 12,722 mn, an increase from the balance as of
หรือ ทรัพยสิ์นอืน ซึ งเป็นผลใหก้องทุนรวมมีความเสียงในสินคา้ หรือตวัแปรทีอา้งอิงนัGน หนา้ 4 ประเภทกองทุนรวม 2.1 กองทุนรวมตราสาร ทุน กองทุนรวมตราสารทุนในประเทศ 1) Equity Small – Mid Cap ลงทุนในหรือมีไวซึ้
ารงความเพยีงพอของเงินกองทุนแปรผนั (variable capital) ตามขนาดของการประกอบธุรกจิ โดยการด ารง adjusted equity ในค่าทีสู่งกว่าระหว่าง (1.2.1) 0.1 % * (AUM4 - 10,000 ล้านบาท) สูงสุดไม่เกนิ 220 ล้านบาท
the negotiation and benefits the Company will receive. 3. Details of connected party and relationship nature : Major shareholder of the Company holding 24.22 percent of total paid-up capital of the
UNOFFICIAL TRANSLATION Readers should be aware that only the original Thai text has legal force and that this English translation is strictly for reference. Notification of the Capital Market
Total Liabilities 4,806 5,871 Total Asset 17,482 17,813 F in an ci al S ta tu s Total Equity 12,676 11,942 • The Company posted net loss in 2nd quarter of year 2017 amounted to THB 233 million which was